Reckitt Benckiser Group plc (RBGLY) Research

Reckitt Benckiser Group plc (RBGLY) is a leading international producer and marketer of consumer health, hygiene, and nutrition products. The company boasts a significant global footprint, with operations spanning key markets such as the United Kingdom, United States, China, and India, among others worldwide. Its extensive product portfolio is divided across several categories. In the consumer health sector, Reckitt provides solutions for various needs, including skincare for blemishes (Clearasil), disinfectants and first aid items (Dettol), sexual health and intimacy products (Durex, K-Y), digestive aids (Gaviscon, Digestive Advantage), and a wide range of respiratory care products for cough, cold, and sinus relief (Mucinex, Delsym, Cepacol). The company also offers pain management solutions (Nurofen, Biofreeze), general wellness supplements like vitamins, minerals, and specialized nutrition for adults and infants (Airborne, Mead Johnson, Move Free, Enfamil, Nutramigen, MegaRed, Neuriva, Bodi-Ome), and depilatories for hair removal (Veet). For household care and hygiene, Reckitt manufactures an array of essentials. These include air fresheners (Air Wick), water treatment additives (Calgon), surface and general home cleaners (Cillit Bang, Easy-Off), dishwashing products (Finish), toilet sanitation solutions (Harpic), pest control items (Lysol, Mortein), laundry detergents and stain removers (Vanish, Woolite, Botanical Origin), and specialized products like septic tank treatments (RID-X). Reckitt Benckiser Group plc was established in 1819 and currently has its corporate headquarters located in Slough, United Kingdom.

Open Reckitt Benckiser Group plc (RBGLY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.